Silexion Therapeutics Corp
SLXN
Last
$0.21
Day
-8.6%
1y
-99.4%
5y
-100.0%
52w
-99.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
0.33
EMA 50
0.86
EMA 200
29.79
20d high
-62.7%
5y high
-100.0%
5y range
0th
Positions held
Your positionsSLXN isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$0.34
Stop
$0.14
Stop distance
34.8%
Target vs last
+58.4%
Fundamentals
| Market cap | $3.40M | Enterprise value | $487,104 | Trailing P/E | — | Forward P/E | -0.37 |
| PEG | — | Price / book | 29.36 | Beta | -0.30 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 32.05 |
| Current ratio | 0.94 | Free cash flow | — | Analyst recommendation | none | Mean target | $5.00 |
| 52w high | $40.70 | 52w low | $0.22 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$3.6M | -$2.7M | -$4.4M | -$3.3M | -$2.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.7M | -$2.7M | -$4.4M | -$3.3M | -$2.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$11.9M | -$16.4M | -$4.9M | -$3.2M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$11.6M | -$12.6M | -$4.7M | -$3.9M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-29 · Silexion Therapeutics Announces Exercise of Warrants
2026-09-09 · Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
2026-08-14 · Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-12 · Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
Price (daily)
Full chart · RSI · MACD · patternsSLXN · daily-40.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin